Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today July 27
June 02, 13:20
UAE Commits Additional $6.26b in Industrial Offtakes
Government enterprises and private companies in the UAE committed an additional $6.26 billion to local manufacturing during the Make it in the Emirates (MIITE) Forum, which concluded on Tuesday. Organ
May 31, 15:05
Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com&esheet=54020000&newsitemid=20240530324847&lan=en-US&anchor=Parse+Biosciences&index=1&md5=af
May 31, 15:00
Rhea Launches with Senior Advisory Panel, Growth Acquisitions and Strategic Partnerships to Advance Fertility Journeys for the Modern Family
Rhea (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rhea-fertility.com%2F&esheet=54023155&newsitemid=20240530629751&lan=en-US&anchor=Rhea&index=1&md5=6bdc47f71fce37fda87be39181
May 30, 16:45
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
JJP Biologics, a private biopharmaceutical company developing innovative antibody-based therapies, announces a positive decision, issued by the European Medicines Agency, on the Clinical Trial Applica
May 30, 16:05
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
Asymchem (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fasymchem.com%2F&esheet=54019791&newsitemid=20240529046363&lan=en-US&anchor=Asymchem&index=1&md5=1c205c848b9ccf2653c34e49187b
May 30, 14:55
Lenovo Powers AI Avatars to Explore the Role of Technology in Mental Health
Today, Lenovo™ released the newest iteration of its Work For Humankind (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Flenovowfh.com%2F&esheet=54018442&newsitemid=20240528448000&lan
May 30, 10:15
Merck Signs MoU with KAIST to Advance Scientific Collaboration
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry c
May 30, 09:30
TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
TVM Capital Healthcare, an international healthcare expansion and growth capital investor, today announced the closing of the TVM Healthcare Afiyah Fund LP at approximately USD 250 million, its second
May 29, 11:55
Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agr
May 28, 14:58
Oncocross and JW Pharmaceutical Team Up on AI-powered Drugs for Cancer and Regeneration
Oncocross, an AI biotech company specializing in drug discovery and development, announced that it has signed a joint research agreement with JW Pharmaceutical to develop new drugs based on the AI pl
May 28, 14:30
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
High-level overall survival (OS) results from the TROPION-Lung01 Phase III trial, which previously met the dual primary endpoint of progression-free survival (PFS), numerically favoured datopotamab de
May 26, 10:55
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an in
May 24, 14:10
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
Merck, a leading science and technology company, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) A
May 23, 14:36
Galderma Launches Restylane® VOLYME™ in China - One of the World’s Fastest Growing Aesthetics Markets
Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane® VOLYME™ in China. The company is also introducing its complementary Shape Up Holistic Individualized
May 22, 17:10
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars
May 22, 14:30
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology,
May 22, 13:40
QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials
QPS, a leading global contract research organization (CRO), continues to expand and align its full-service preclinical, bioanalysis, and clinical capabilities with the evolution of demand for clinical
May 22, 11:35
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches
Kinaxis (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54001339&newsitemid=20240521977758&lan=en-US&anchor=Kinaxis&index=1&md5=5f9eae6c7e7cdf798bb35930e
May 22, 11:00
Carestream Introduces Image Suite MR 10 Software to Enhance Imaging Experience for CR and DR Imaging Systems
Carestream launches its Image Suite MR 10 Software to help deliver a boost to productivity and efficiency while enabling a more user-friendly imaging experience for radiographers. Carestream’s Imag
May 16, 16:44
New Award Programme From Oral-B and the International Association for Disability and Oral Health (iADH) Champions Disability Positive Dental Practices Across Europe
Today, on Global Accessibility Awareness Day (GAAD), Oral-B proudly launches the Disability Champions Award Programme as part of its ongoing mission to make oral care more accessible to everybody. In
May 16, 16:00
FinalSpark Launches the First Remote Research Platform Using Human Neurons for Biocomputing
FinalSpark, a pioneering Swiss biocomputing startup, has launched the first-ever online platform enabling global researchers to conduct experiments remotely on biological neurons in vitro. The platfor
May 16, 14:20
Optiscan Signs Know-How Agreement with Mayo Clinic
Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to develop a digital conf
May 16, 13:09
Todd Clegg Named Carestream’s Chief Executive Officer
Carestream, a world-leading provider of medical imaging systems and non-destructive testing solutions, announced that Todd Clegg has been named CEO and appointed to the Board of Directors, effective i
May 16, 10:03
MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced it will present positive data for its lead as
May 15, 10:30
Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
Takeda (TSE: 4502/NYSE:TAK) (https://www.takeda.com/investors/overview/) today announced that it will present data from its oncology pipeline and product portfolio at the 60th Annual Meeting of the Am
May 14, 14:10
GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.
Graminex®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The
May 14, 09:55
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2F&esheet=53983823&newsitemid=20240510475155&lan=en-US&anchor=Takeda&index=1&md5=4a403ee030780c54b5ebde46e786f5
May 13, 10:20
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Manage
May 10, 14:55
BeiGene Reports First Quarter 2024 Financial Results and Business Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=53978747&newsitemid=20240508878785&lan=en-US&anchor=BeiGene&index=1&md5=289a1210b11d33d3f6dbd570f8e
May 09, 15:40
LC-Plasma-based Vaccine Research Selected for SCARDA Project
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis str
May 09, 13:55
Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML
A groundbreaking research study,[1] sequencing DNA samples from the Pre-MEASURE study[2] strongly indicates that the detection of residual FLT3 internal tandem duplication (ITD) mutations in the blood
May 07, 14:35
Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic derm
May 07, 11:30
Parse Biosciences Launches Single Cell Immune Profiling Products
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its existing Evercode™ TCR pro
May 03, 10:35
Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer
Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 bi
May 01, 12:55
WHOOP Announces Significant Global Expansion, Appoints New Senior Leadership
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F&esheet=53961244&newsitemid=20240429085870&lan=en-US&anchor=WHOOP&index=1&md5=208ea6634cca605d44e019265ce45daf)
April 28, 13:10
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended
April 28, 11:40
CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology
Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO
April 25, 17:05
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts. As detailed in its complaint, Exergen’s lawsuit i
April 25, 14:55
Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation provi
April 24, 14:34
Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. · Record net sales of 1.071 billion USD in the first qu
April 24, 10:10
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939040&newsitemid=20240423657886&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md
April 24, 09:30
ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA tec
April 23, 16:50
AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand
AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand (herein
April 23, 15:45
Toyoda Gosei Develops UV-C LED with World-Class Light Output
Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed deep ultraviolet (UV-C) LEDs with light output that is among the highest in the world.[1] UV-C is used in disinfection as it destroys viral and bacter
April 23, 09:45
Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital
Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939039&newsitemid=20240422384739&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md
April 18, 15:40
The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report
A new report published today reveals that adult vaccination programmes can return up to 19 times their initial investment when the full spectrum of economic and societal benefits is valued. The 19x re
April 18, 14:15
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
Masimo (https://www.masimo.com/en-us/) (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patien
April 18, 08:00
INB Korea Ltd removes the bubble of the price on air sterilizer, cutting the price by 70% , NEW ‘UPPERVIOLET ODEO’ product is launched
INB Korea Ltd, the manufacturer of ‘viruskiller’, a K- air purifier and sterilizer product in Korea that exported 20 million dollar to 53 countries during the COVID19 outbreak, announced on the 17th o
April 17, 09:57
A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer
Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos a
April 17, 09:15
MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clin
«
1
2
3
4
5
»
50 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice